Cambridge Nutritional Sciences (CNSL) Stock Chart & Stock Price History → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free CNSL Stock Alerts GBX 3.89 -0.06 (-1.57%) (As of 05/3/2024 04:21 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Cambridge Nutritional Sciences Stock Price Performance5 Day Performance+0.70%1 Month Performance+17.04%3 Month Performance+38.86%Year-To-Date Performance+59.41% Receive CNSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. CNSL Stock Chart for Sunday, May, 5, 2024 CNSL Chart by TradingView Cambridge Nutritional Sciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024GBX 3.89GBX 3.89GBX 4.03GBX 3.86127,670 shs£9.25 million05/02/2024GBX 3.88GBX 3.89+0.34%GBX 4.08GBX 3.88167,297 shs£9.25 million05/01/2024GBX 3.86GBX 3.88+0.36%GBX 4GBX 3.86937,118 shs£9.22 million04/30/2024GBX 3.83GBX 3.86+0.73%GBX 3.86GBX 3.85962,099 shs£9.19 million04/29/2024N/AGBX 3.83GBX 4GBX 3.702.09 million shs£9.12 million04/26/2024GBX 3.90GBX 3.87-0.77%GBX 3.88GBX 3.75623,930 shs£9.21 million Get the Latest News and Ratings for CNSL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024N/AGBX 3.90GBX 4.02GBX 3.751.18 million shs£9.28 million04/23/2024GBX 3.71GBX 4.09+10.21%GBX 4.09GBX 3.693.10 million shs£9.73 million04/22/2024N/AGBX 3.71GBX 4GBX 3.394.65 million shs£8.83 million04/19/2024GBX 3.20GBX 3.28+2.50%GBX 3.28GBX 3.289,898 shs£7.81 million04/18/2024GBX 3.20GBX 3.20GBX 3.30GBX 3.20152,847 shs£7.61 million04/17/2024GBX 3.32GBX 3.20-3.67%GBX 3.32GBX 3.20360,734 shs£7.61 million04/16/2024GBX 3.36GBX 3.32-0.98%GBX 3.36GBX 3.3286,245 shs£7.91 million04/15/2024N/AGBX 3.36GBX 3.38GBX 3.3633,500 shs£7.98 million04/12/2024GBX 3.36GBX 3.36-0.03%GBX 3.40GBX 3.3557,656 shs£7.98 million04/11/2024GBX 3.38GBX 3.36-0.56%GBX 3.40GBX 3.31239,344 shs£7.99 million04/10/2024N/AGBX 3.38GBX 3.47GBX 3.21219,129 shs£8.03 million04/08/2024N/AGBX 3.32GBX 3.44GBX 3.32173,447 shs£7.91 million04/05/2024GBX 3.33GBX 3.32-0.24%GBX 3.49GBX 3.31446,673 shs£7.91 million04/04/2024GBX 3.31GBX 3.33+0.60%GBX 3.38GBX 3.31132,179 shs£7.92 million04/03/2024GBX 3.31GBX 3.31-0.06%GBX 3.39GBX 3.31351,154 shs£7.88 million04/02/2024N/AGBX 3.31GBX 3.49GBX 3.30940,455 shs£7.88 million03/29/2024N/AGBX 3.45GBX 3.73GBX 3.33807,157 shs£8.21 million03/27/2024GBX 3.46GBX 3.58+3.26%GBX 3.79GBX 3.462.33 million shs£8.51 million03/26/2024N/AGBX 3.46GBX 3.60GBX 3.231.01 million shs£8.24 million03/22/2024GBX 3.28GBX 3.21-2.16%GBX 3.48GBX 3.13201,932 shs£7.64 million03/21/2024GBX 3.30GBX 3.28-0.55%GBX 3.39GBX 3.23104,939 shs£7.81 million03/20/2024GBX 3.24GBX 3.30+1.82%GBX 3.50GBX 3.011.17 million shs£7.85 million03/19/2024GBX 3.08GBX 3.24+5.37%GBX 3.28GBX 3.08319,701 shs£7.71 million03/18/2024GBX 2.95GBX 3.08+4.24%GBX 3.15GBX 2.96804,723 shs£7.32 million03/15/2024GBX 3.01GBX 2.95-2.03%GBX 3.13GBX 2.95315,187 shs£7.02 million03/14/2024GBX 2.92GBX 3.01+3.05%GBX 3.14GBX 2.931.00 million shs£7.17 million03/13/2024GBX 3GBX 2.92-2.60%GBX 3.20GBX 2.922.12 million shs£6.95 million03/12/2024GBX 2.66GBX 3+12.78%GBX 3GBX 2.571.20 million shs£7.14 million03/11/2024N/AGBX 2.66GBX 2.67GBX 2.53265,369 shs£6.33 million03/08/2024GBX 2.57GBX 2.56-0.27%GBX 2.73GBX 2.53722,887 shs£6.09 million03/07/2024GBX 2.57GBX 2.57-0.08%GBX 2.57GBX 2.56148,406 shs£6.11 million03/06/2024GBX 2.56GBX 2.57+0.27%GBX 2.63GBX 2.5685,897 shs£6.11 million03/05/2024GBX 2.70GBX 2.56-5.11%GBX 2.79GBX 2.52202,043 shs£6.10 million03/04/2024N/AGBX 2.70GBX 2.70GBX 2.52484,657 shs£6.43 millionAutomatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free.03/01/2024GBX 2.66GBX 2.55-4.14%GBX 2.64GBX 2.50756,169 shs£6.07 million02/29/2024GBX 2.52GBX 2.66+5.64%GBX 2.67GBX 2.54419,532 shs£6.33 million02/28/2024GBX 2.54GBX 2.52-0.67%GBX 2.54GBX 2.52149,839 shs£5.99 million02/27/2024GBX 2.54GBX 2.54GBX 2.64GBX 2.54158,448 shs£6.03 million02/26/2024N/AGBX 2.54GBX 2.68GBX 2.51103,446 shs£6.03 million02/23/2024GBX 2.61GBX 2.70+3.37%GBX 2.70GBX 2.551.07 million shs£6.43 million02/22/2024GBX 2.55GBX 2.61+2.43%GBX 2.83GBX 2.51502,924 shs£6.22 million02/21/2024GBX 2.51GBX 2.55+1.80%GBX 2.66GBX 2.51295,601 shs£6.07 million02/20/2024GBX 2.63GBX 2.51-4.57%GBX 2.85GBX 2.5123,662 shs£5.96 million02/19/2024N/AGBX 2.63GBX 2.63GBX 2.55259,548 shs£6.25 million02/16/2024GBX 2.75GBX 2.63-4.55%GBX 2.98GBX 2.6183,385 shs£6.25 million02/15/2024GBX 2.53GBX 2.75+8.91%GBX 2.75GBX 2.51566,000 shs£6.54 million02/14/2024GBX 2.55GBX 2.53-0.90%GBX 2.55GBX 2.5341,779 shs£6.01 million02/13/2024GBX 2.58GBX 2.55-1.24%GBX 2.80GBX 2.50125,085 shs£6.06 million02/12/2024N/AGBX 2.58GBX 2.80GBX 2.58176,774 shs£6.14 million02/09/2024GBX 2.66GBX 2.83+6.23%GBX 2.83GBX 2.58258,781 shs£6.73 million02/08/2024N/AGBX 2.66GBX 2.67GBX 2.50114,495 shs£6.33 million02/06/2024GBX 2.80GBX 2.68-4.29%GBX 2.85GBX 2.56308,960 shs£6.37 million02/05/2024N/AGBX 2.80GBX 2.89GBX 2.65172,012 shs£6.66 million Related Companies: ImmuPharma Stock Chart LungLife AI Stock Chart Argent BioPharma Stock Chart BiVictriX Therapeutics Stock Chart Totally Stock Chart Polarean Imaging Stock Chart Shield Therapeutics Stock Chart Proteome Sciences Stock Chart Kanabo Group Stock Chart Chill Brands Group Stock Chart Receive CNSL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CNSL) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityAutomatic Income (from home)Awesomely, LLCThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.